[
    [
        {
            "time": "2021-11-05",
            "original_text": "Stocks: Travel and crypto dip, retail rallies, pharmaceuticals rise",
            "features": {
                "keywords": [
                    "travel",
                    "crypto",
                    "retail",
                    "pharmaceuticals"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "travel",
                    "cryptocurrency",
                    "retail",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Stocks: Travel and crypto dip, retail rallies, pharmaceuticals rise",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-11-05",
            "original_text": "Pfizer (PFE) Seeks FDA's Emergency Use Nod for COVID Pill",
            "features": {
                "keywords": [
                    "Pfizer",
                    "FDA",
                    "COVID",
                    "pill"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Pfizer (PFE) Seeks FDA's Emergency Use Nod for COVID Pill",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-11-05",
            "original_text": "Lilly to Participate in Fourth Annual Evercore ISI HealthCONx Conference",
            "features": {
                "keywords": [
                    "Lilly",
                    "Evercore",
                    "ISI",
                    "HealthCONx",
                    "Conference"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Lilly to Participate in Fourth Annual Evercore ISI HealthCONx Conference",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-11-05",
            "original_text": "3 Big Pharma Outperformers to Watch Out For in the Near Term",
            "features": {
                "keywords": [
                    "Big",
                    "Pharma",
                    "Outperformers",
                    "Near",
                    "Term"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "3 Big Pharma Outperformers to Watch Out For in the Near Term",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-11-05",
            "original_text": "Glaxo and Vir Report $1 Billion Sale of Covid-19 Antibody. The U.S. Is Still Buying.",
            "features": {
                "keywords": [
                    "Glaxo",
                    "Vir",
                    "Covid-19",
                    "Antibody",
                    "U.S."
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Glaxo and Vir Report $1 Billion Sale of Covid-19 Antibody. The U.S. Is Still Buying.",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-11-05",
            "original_text": "Could Eli Lilly Leapfrog Biogen in This Market?",
            "features": {
                "keywords": [
                    "Eli",
                    "Lilly",
                    "Leapfrog",
                    "Biogen",
                    "Market"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Could Eli Lilly Leapfrog Biogen in This Market?",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]